Topic: Anemia
SILVER SPRING, Maryland (Reuters) - A new Affymax Inc drug won expert backing to treat anemia in patients with chronic kidney disease who are on dialysis.A Food and Drug Administration advisory panel voted 15-1 on Wednesday, with one abstention, that peginesatide's benefits ...
(Reuters) - Amgen Inc, aiming to secure future sales of its flagship anemia drug Epogen as potential competition emerges, has reached new supply contracts with the two largest operators of U.S. kidney dialysis clinics.The biotechnology company said in a regulatory filing on ...
(Reuters) - Amgen Inc reached a seven-year contract to supply DaVita Inc with nearly all of the anemia drugs needed by the dialysis clinic operator, locking up nearly a third of the U.S. market for its flagship drug Epogen.Amgen said in a ...
LOS ANGELES (Reuters) - The Medicare federal health insurance program has confirmed plans to remove a requirement that kidney dialysis providers keep patient hemoglobin levels above a set minimum -- a move likely to reduce use of Epogen, the anemia drug sold ...
LOS ANGELES (Reuters) - The Medicare federal health insurance program has proposed removing its requirement that kidney dialysis providers keep patient hemoglobin levels above a set minimum, which could lead to lower use of Epogen, the anemia drug sold by Amgen.The government ...
LOS ANGELES (Reuters) - Medicare officials do not plan at this time to change payment terms for anemia drugs used in kidney patients who are undergoing dialysis.The agency, which is slated to issue a final decision on the matter in June, also ...
Shares of Amag Pharmaceuticals Inc. soared Monday after the drug maker said it reached an agreement with regulators on an updated product label for the anemia drug Feraheme.. The updated product label also includes an increased observation period to 60 minutes from ...
Hemolytic anemia is a type of anemia that is characterized by progressive destruction of red blood cells or erythrocytes. In addition, it can occur due to a biochemical or physical agent that can destroy the red blood cells. Accelerated death of red ...
This aim of study was to determine the prevalence of anemia among infants from 4 to 11 months age and also to evaluate possible related risk factors with anemia. Study group was occurred 3039 healthy infants (51.4% boy) from 4 to 11 ...
People with chronic? kidney disease do not make enough of the hormone erythropoietin which helps the body produce red blood cells. Epogen is a medication that is frequently used to help increase the number of red blood cells in the body. Epogen ...
